Focal adhesion kinase (FAK) is a nonreceptor protein tyrosine kinase and a major phosphotyrosine-containing protein. FAK is found in cell-matrix attachment sites (focal adhesions), and is activated on integrin-ligand binding and by other signaling pathways. Several roles have been proposed for FAK; here we report a novel function. We observed abundant FAK protein in all human melanoma cell lines tested except COLO839, a line that grows predominantly in suspension and was derived from peripheral blood. Five adherent lines, isolated from solid metastases in the same patient as COLO839, did express FAK. We derived four adherent sublines from COLO839. These did express FAK, even when plated on bacteriological plastic, to which they did not adhere. Thus, substrate attachment was not required for FAK expression. Three of the adherent sublines were then grown in the presence of antisense oligonucleotides to the initial FAK coding sequence. All showed substantially reduced FAK expression and, interestingly, the cells largely detached from the substrate while continuing to grow. Similar results were obtained with an independent melanoma line, DX3. Thus, FAK expression appears to be required by melanoma cells for substrate adhesion.
Focal adhesion kinase (FAK) is a cytosolic protein of 125 kDa, ®rst recognized as a major phosphotyrosinecontaining protein in ®broblasts, and as a major substrate of the viral oncoprotein and protein tyrosine kinase (PTK), v-Src (Kanner et al., 1990) . FAK, or pp125 FAK , proved to be a nonreceptor PTK itself , Hanks et al., 1992 . FAK colocalizes with components of cellular focal adhesions (subcellular structures formed at regions of close contact between a cell and its substrate), such as tensin, vinculin and talin (IlicÂ et al., 1997) . Chicken, murine, two human and Xenopus cDNA sequences have been reported Hanks et al., 1992; AndreÂ and Becker-AndreÂ , 1993; Whitney et al., 1993; Zhang et al., 1995) .
FAK is highly conserved among vertebrates and ubiquitously and highly expressed in vivo; deletion of its gene is lethal early in development (for reviews see Richardson and Parsons, 1995; Otey, 1996 , IlicÂ et al., 1997 Hanks and Polte, 1997) . Several functions have been proposed for this kinase. Much evidence supports a role in signaling from integrins on cell adhesion. Integrins bind to FAK within focal adhesions, and their activation by extracellular matrix ligands is associated with increased tyrosine phosphorylation and kinase activity of FAK (Burridge et al., 1992; Guan and Shalloway, 1992; Kornberg et al., 1992) . FAK phosphorylation is also increased by various growth factors, including platelet-derived growth factors and endothelin 1 (for reviews see Rozengurt, 1995; Otey, 1996; IlicÂ et al., 1997) . As with receptor tyrosine kinases, various cellular signaling molecules associate with activated, phosphorylated FAK (for review see Hanks and Polte, 1997) . These include cellular SRC and the related FYN; GRB2 (potentially activating RAS and MAPK signaling) (Schlaepfer et al., 1994) , and phosphatidylinositol 3-kinase, through which integrins can activate an anti-apoptotic pathway via the AKT kinase (Khwaja et al., 1997) . These ®ndings suggest roles for FAK in signaling of cell proliferation and cell survival, in response to both cellmatrix attachment and soluble mitogenic peptides. Speci®cally, FAK may mediate anchorage-dependence, the requirement of most normal cells for substrate-attachment, to survive and proliferate. Apoptotic cell death in the absence of matrix attachment has been termed`anoikis' (Frisch et al., 1996; Khwaja et al., 1997) . Epithelial cell lines expressing an exogenous activated FAK were resistant to this anoikis and could grow in suspension (Frisch et al., 1996) . FAK also appears to promote cell survival more generally, since attenuation of FAK expression by growth with antisense oligonucleotides accelerated spontaneous or induced apoptosis in various tumor cells including a melanoma line (Xu et al., 1996; Sonoda et al., 1997) .
Evidence for further functions of FAK emerged from studies with FRNK (FAK-related non-kinase), the non-catalytic carboxy-terminal domain of FAK, expressed separately in some cells via an alternative translation-initiation site. FRNK can inhibit FAK functions when overexpressed. Respreading of trypsin-detached cells and focal-adhesion assembly were both de®cient in chick ®broblasts overexpressing FRNK; and further evidence supported these as additional functions for FAK (Richardson and Parsons, 1996; Richardson et al., 1997) . Conversely, other data supported roles in focal adhesion disassembly, and cell movement. Fibroblast-like cells from FAK-null mouse embryos had abnormally high numbers of focal contacts but reduced motility , associated with de®cient development of mesoderm in vivo . In these embryonic cells, FAK was evidently not required for focal adhesion assembly. Similarly a preliminary correlation was reported between increased motility and increased FAK expression, among six melanoma cell lines (Akasaka et al., 1995) . FAK functions or requirements may well dier among dierent cell types. More generally, increased FAK expression has been correlated with invasive and metastatic potential in human tumors (Weiner et al., 1993 , Owens et al., 1995 , lending clinical signi®cance to the elucidation of its functions in malignant cells.
Previously we (Easty et al. (1993) and Lee et al. (1993) ) identi®ed a novel partial PTK cDNA sequence in malignant melanoma cells and normal melanocytes, initially calling it MEK and PTK2 respectively. Identity of both sequences with human FAK (AndreÂ and Becker-AndreÂ , 1993; Whitney et al., 1993) emerged subsequently. The high transcript levels for FAK, assessed by us to be higher than those for any other of the 25 or so PTKs we have analysed in pigment cells (Easty et al., 1993 (Easty et al., , 1995 (Easty et al., , 1997 , suggested a major role for FAK gene products in these cells, which we have now investigated.
Immunoblot analysis showed that, as with its mRNA levels (Easty et al., 1993) , FAK protein was highly expressed in nearly all melanoma lines tested ( Figure 1a ). It appeared to be overexpressed in line RPMI 7932, in accordance with the high mRNA level seen previously (Easty et al., 1993) . However no FAK protein was detectable in one line, COLO839 ( Figure 1a To test the possibility of a causal connection between cell attachment and FAK expression, we derived four independent adherent sublines from the minor adherent cell subpopulation of line COLO839. The attached phenotype appeared to remain stable during the few subcultures required to expand these sublines for analysis; nonadherent cells were not regenerated ( Figure 2b ). These four attached sublines were tested for FAK protein, and all were found to express it ( Figure 1c , lanes 1 ± 4).
One possible explanation of these ®ndings was that FAK expression was dependent on cell-substrate adhesion. This was tested by plating three of the adherent sublines of COLO839 on to bacteriological dishes, on which mammalian cells generally fail to adhere. The sublines did fail to adhere, growing well in COLO839 was derived from peripheral blood of a melanoma patient, while adherent lines COLO829, 832, 845, 857 and 858 were from solid metastases from the same patient (Morse and Moore, 1993; GE Moore, personal communication). These lines and RPMI 7932 were provided by GE Moore (Department of Health and Hospitals, Denver, CO, USA). COLO839 cells expressed mRNAs for melanocyte-speci®c enzymes, tyrosinaserelated protein 1 and dopachrome tautomerase (Northern blot data, DJE, not shown), con®rming that they were melanoma cells. Sources of other lines were as listed before (Easty et al., 1995 (Easty et al., , 1997 . All melanoma lines were maintained in RPMI 1640 medium with 5% (v/v) fetal calf serum and 10% (v/v) CO 2 . To obtain adherent subclones of COLO839, adherent cells were selected by aspiration of¯oating cells and extensive rinsing, then trypsinized and replated at very low density. Four well-separated colonies were trypsinized using plastic cloning rings, expanded, and designated C839-1 to -4. For immunoblot analysis, cell samples were lysed in 0.5 ml boiling denaturing lysis buer (1% SDS, 10 mM Tris.HCl, pH 7.4, 2 mM EDTA) with 5 mM phenylmethylsulfonyl¯uoride, 2 mg/ml aprotinin and 1 mM sodium orthovanadate. The suspension was passed through a needle three times to shear DNA, boiled for 5 min, and supernatants placed at 7708C. Protein concentrations were determined by the BCA assay (Pierce, Chester, UK). Lysates (13 mg of protein per lane) were electrophoresed through a 7.5 or 10% polyacrylamide gel containing SDS, and transferred to nitrocellulose membranes (Anderman & Co., Kingston, UK). The membranes were blocked in 0.2% Tween-20 and 5% (w/v) dried milk in phosphate-buered saline (PBS) for 30 min at 378C, then incubated with the same solution containing anti-FAK (1/500) (Aniti Research Products, Exeter, UK), a mouse IgG1 monoclonal antibody against amino acids 354 ± 533 of chicken Fak. After six washes of 5 min in PBS with 0.2% Tween-20, membranes were incubated with an anti-mouse IgG coupled to horseradish peroxidase (1/1000) (Amersham, Aylesbury, UK), for 30 min at 378C. FAK was visualized with an enhanced chemiluminescence kit (ECL, Amersham) according to the manufacturer's instructions. To assess loading, membranes were stripped in 100 mM mercaptoethanol, 2% SDS and 62.5 mM Tris.HCl, pH 6.8, for 30 min at 508C, and reprobed with an anti-glyceraldehyde phosphate dehydrogenase (GAPDH) antibody (mouse monoclonal; 1/300) (Chemicon International, Harrow, UK), and the same second antibody suspension, and still expressed FAK protein (Figure 1c , lanes marked B), showing that attachment to a substrate was not required for FAK expression.
Conversely, it was possible that cell attachment required FAK expression. This was tested by the use of antisense oligodeoxynucleotides to interfere with FAK expression. Three adherent sublines were grown for 4 days in medium supplemented daily with antisense phosphorothioate oligonucleotides to the ®rst 21 bases of the FAK coding sequence. The same sequence in the sense orientation, and cells with no oligonucleotides, were used as controls. All three sublines grown with the antisense FAK sequence showed a considerable degree of cell detachment from the substrate (over 50%; Figures 3 and 4a) . Counts of dead cells using trypan blue (not shown) indicated that most of these detached cells were alive, in accordance with the refractile appearance of the cells by phase contrast (Figure 3c) . Moreover, the total cell number increased as rapidly with antisense oligonucleotides (24-fold increase over 4 days) as with sense or no oligonucleotides (22-fold over 4 days), so that an increased death rate or toxic eect was very unlikely. There was a slight increase in cell detachment after growth with sense oligonucleotides, suggesting some nonspeci®c eect of the treatment protocol on attachment, but the detachment was much greater with the antisense sequence (dierence highly signi®cant), indicating a sequence-speci®c eect (Figures 3 and 4a) .
Immunoblot analysis con®rmed reduced FAK protein levels relative to GAPDH protein, after growth with antisense oligonucleotides, to about 30% of those in cultures grown with sense or no oligonucleotides ( Figure  4c,d) . In case this behavior was an idiosyncrasy of one tumor cell line, the same analysis was performed with an independent adherent melanoma cell line, DX3. This line too showed a substantial reduction in FAK expression on treatment with antisense oligonucleotides, accompanied once more by marked cell detachment from the substrate without reduction in net cell proliferation (Figure 4b,d) .
In summary, three lines of evidence show that FAK gene expression is required for substrate adhesion in cultured melanoma cells. Firstly, among six related , and were phosphorothioate-modi®ed for stability (Crooke and Bennett, 1996) . The protocol was modi®ed from Miele et al. (1994) . Melanoma cells were plated sparsely (5610 3 cells/ml, 2 ml), in 3-cm dishes and grown until about halfcon¯uent. The medium was replaced by RPMI 1640 containing 0.5% heat-inactivated FCS to reduce growth rate. Oligonucleotides (®nal concentration 0.7 mM) were used with Lipofectin (Life Technologies, Paisley, Scotland; ®nal concentration 15 mg/ml), to enhance uptake (Crooke and Bennett, 1996) . These were mixed as concentrates, left for 15 min to complex, and added to cultures. The same amount of the same mixture was re-added after every 24 h incubation melanoma lines from the same patient, FAK expression was absent only from the line derived from peripheral blood, COLO839, which grew mostly in suspension. Moreover, four clonal sublines derived from the few attached COLO839 cells all did express FAK. Secondly, when attachment of adherent COLO839 sublines was blocked by growth on bacteriological plastic, FAK was still expressed, so attachment was not required for this. Thirdly, when FAK expression was attenuated using antisense oligodeoxynucleotides, in attached sublines of COLO839, and in melanoma line DX3, over 50% of the cells detached in 4 days, but with no detectable increase in cell death nor even inhibition of proliferation.
It may seem surprising that this function has not been elucidated before. Cell attachment is distinct from cell spreading as de®ned by Richardson et al. (1997) . However, the functions of FAK may dier between dierent cells, as already remarked. FAK was apparently not required for attachment of the ®broblast-like cells that grew out from FAK-null mouse embryos . It is not clear what these cells were, and one suggestion is that they were of the smooth-muscle cell lineage, since such cells appear able to spread and form focal adhesions without activated FAK (Otey, 1996 and literature cited) . Similarly, FAK expression was attenuated in ovarian cancer cells (Shibata et al., 1998) , or in osteoblastic cells (Takeuchi et al., 1997) , without any detachment being reported, although other eects were observed. Other FAK-related proteins have been described (IlicÂ et al., 1997) , and these may have roles that overlap with that of FAK in some cells.
Conversely, there may be a variety of cell types that do require FAK for attachment; but that die when not attached (anoikis; Frisch et al., 1996) . This may have been what happened in a melanoma line and two other tumor cell lines studied by Xu et al. (1996) , in which the cells both detached and underwent apoptosis when FAK expression was attenuated by growth with antisense oligonucleotides. In this circumstance it is dicult to say whether the cells detached because they died, or died because they detached. Xu et al. (1998) also described cell detachment and subsequent death in tumor cells expressing the carboxy-terminal domain of FAK (interfering with FAK function); here it becomes more likely that the death was due to detachment, but Following immunoblot analysis, as in (c), FAK abundance was measured by laser densitometry, normalized to that for GAPDH protein in each line, and then expressed as a percentage of the abundance in line C839-1 with no added oligonucleotides (`control'). Bars show normalized FAK levels after growth with (unshaded): no oligonucleotides; (black): antisense, and (shaded): sense oligonucleotides.`Clones 1, 2 and 3' indicate sublines C839-1, -2, -3. Means and standard errors from triplicate cultures. After growth with antisense oligonucleotides, FAK abundance is only around 30% of control levels it is also possible that the cells detached on becoming unhealthy prior to death. In the present report however, no induced death nor even a deceleration of proliferation was seen in either melanoma line, separating the two eects cleanly.
Apparently not all melanoma lines can grow in suspension. Here, however, we began with subclones of a parental line known to grow in suspension, and it transpired that the unrelated line studied, DX3, was also viable in suspension. Melanoma cells are notoriously resistant to apoptosis (and thus to chemotherapy and radiotherapy). They derive from a cell lineage (melanocytes) that normally expresses the anti-apoptotic factor BCL2, and tend to retain this (van den Oord et al., 1994) . This is not sucient to allow growth in suspension however; normal melanocytes were reported to die when cell attachment was blocked, this being prevented by attachment to ®bronectin (Scott et al., 1997) . Moreover a metastatic melanoma line that did grow in suspension expressed constitutively phosphorylated FAK (Scott and Liang, 1995) . This is clearly not the only route to tumor cell survival in suspension, since COLO839 has no detectable FAK. It may be relevant that other PTKs are commonly overexpressed in cancer cells, including malignant melanoma cells (e.g. Easty et al., 1993 Easty et al., , 1995 Easty et al., , 1997 , providing other potential routes for activation of the PI-3 kinase-AKT anti-apoptotic pathway.
It is intriguing that the COLO839 melanoma cell line, derived unusually from peripheral blood, expresses no detectable FAK. FAK downregulation might assist early metastatic spread, enabling vascular circulation of tumor cells without adhesion. Conversely, later stages may be promoted by FAK, since we and others (Easty et al., 1993; Akasaka et al., 1995) found higher FAK expression in metastatic than other melanoma lines. Circulating tumor cells that reexpressed FAK could attach to endothelium and potentially form metastatic deposits.
